FACTS ABOUT CONOLIDINE REVEALED

In 2011, the Bohn lab pointed out antinociception versus equally chemically induced and inflammation-derived agony, and experiments indicated lack of opioid receptor modulation, but have been struggling to determine a specific focus on."The invention of ACKR3 being a focus on of conolidine even more emphasises the part of the freshly found receptor